- VTR +0.66%
Search results
- 47.50Add to watchlist+0.31 (+0.66%)At close:4:00 PM EDTFri. May 24, 202447.50 0.00 (0.00%)Pre mkt:8:00 AM EDTTue. May 28, 2024Nasdaq Real Time Price (USD) · Pre-Market Time
- Open47.60High47.97Low47.29
- Mkt Cap19.23BP/E (TTM)N/ADiv & Yield1.80 & 3.79%
- Prev. Close47.1952 Wk. Low39.3352 Wk. High50.99
What analysts are sayingTop storiesInsider Sale: Director Walter Rakowich Sells Shares of Ventas Inc (VTR)Yahoo Finance · 2 weeks ago- VTR +0.66%
Insider Sale at Ventas Inc (VTR): SVP, Chief Accounting Officer Gregory Liebbe Sells SharesYahoo Finance · 2 weeks ago3 Cheap REITs to Buy Now: May 2024Yahoo Finance · 2 weeks agoRelated stocks
38.81. -1.99%. Find the latest Ventas, Inc. (VTR) stock quote, history, news and other vital information to help you with your stock trading and investing.
May 21, 2024 · Get the latest VTR stock price, performance, analyst ratings, and news on MarketWatch. Ventas Inc. is a healthcare real estate investment trust that owns and operates senior housing and healthcare properties.
People also ask
Should you buy Ventas (VTR) stock?
What are VTR share price targets?
What does VTRs stock mean?
Is VTRs a good stock to buy according to hedge funds?
Get the latest Ventas Inc (VTR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Apr 8, 2024 · Get the latest stock price, key data, dividend, and earnings information for Ventas, Inc. (VTR), a real estate investment trust. See how VTR performs in the market and compare it with other ETFs and REITs.
5 days ago · A high-level overview of Ventas, Inc. (VTR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Per-Share Earnings, Actuals and Estimates. View the latest Ventas Inc. (VTR) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Ventas is a healthcare REIT that owns and operates senior housing, medical office, hospital, and life science properties. The stock is trading at a 37% discount to fair value and has a 4.11% dividend yield as of May 1, 2024.